Nishadil
Signup Signin
Delhi | 25°C (windy) | Air: 185%

Paxlovid does not lower risk of long term COVID 19 symptoms, UCSF study shows

  • Nishadil
  • January 05, 2024
  • 0 Comments
  • 0.22 minutes read
  • 8 Views
Paxlovid does not lower risk of long term COVID 19 symptoms, UCSF study shows
The popular COVID treatment, Paxlovid, does not significantly lower the risk of "long COVID" for people who are vaccinated. In a , researchers found that patients who took Paxlovid and those who did not had similar outcomes when it came to long COVID symptoms. Researchers also found a higher than expected COVID rebound for patients who took the medication. Paxlovid has been shown to be effective for high risk, unvaccinated people.
Elise Stefanik Withdraws Endorsement Of GOP Candidate Who Mildly Criticized Trump

Elise Stefanik Withdraws Endorsement Of GOP Candidate Who Mildly Criticized Trump
House Democrats accuse Trump of raking in $7.8 million in foreign payments while president

House Democrats accuse Trump of raking in $7.8 million in foreign payments while president
PA Senate candidate McCormick recounts IDF visit, deems Israel Hamas war 'test' for American leadership

PA Senate candidate McCormick recounts IDF visit, deems Israel Hamas war 'test' for American leadership
South Dakota Gov Noem stumps for Trump in Iowa, says Nikki Haley would be 'mistake' as his running mate

South Dakota Gov Noem stumps for Trump in Iowa, says Nikki Haley would be 'mistake' as his running mate
Even far below freezing, ice's surface begins melting as temperatures rise

Even far below freezing, ice's surface begins melting as temperatures rise
Breaking the 10 petawatt limit with a new laser amplification

Breaking the 10 petawatt limit with a new laser amplification
A renegade moon may have flipped Venus’s spin

A renegade moon may have flipped Venus’s spin